Target intelligence / Profile preview

HIV Negative Regulatory Factor (HIV Nef)

Target
HIV Nef
Molecular classification
Other (Viral accessory protein), not a conventional receptor, enzyme, or transporter
01

Overview

HIV Negative Regulatory Factor (Nef) is a small, myristoylated accessory protein (27–35 kDa) encoded by primate lentiviruses including HIV-1 and HIV-2[1][7]. Despite its name, Nef is a central facilitator of HIV pathogenesis, enhancing viral replication, promoting immune evasion, and accelerating disease progression. Nef lacks intrinsic enzymatic activity and instead exerts its effects via multiple protein-protein interactions with host cellular machinery. Major biological roles include downregulation of CD4 and MHC I molecules from the cell surface—thereby enabling infected cell escape from immune surveillance—modulation of T cell receptor signaling, alteration of endosomal trafficking, and promotion of T cell activation environments favorable for viral persistence[1][4][7]. Nef is composed of a flexible, myristoylated N-terminal membrane anchor and a structured core, which together mediate binding to host kinases and adaptor protein complexes involved in trafficking[1][6]. Loss or mutation of Nef dramatically reduces HIV virulence, and attempts to therapeutically inhibit its actions are ongoing, though no Nef-directed drugs are approved to date[1][7].

Other names
NefNegative Regulatory Factornef protein
02

Mechanism of action

Disruption of Nef-mediated protein-protein interactions (with host kinases, adaptor protein complexes, etc.)[1][4]

03

Biological functions

Immune response modulationSignal transductionDownregulation of host membrane proteins (CD4, MHC-I)Viral replication and pathogenesis
04

Disease associations

Infection (AIDS/HIV infection progression)
05

Safety considerations

Targeting Nef must carefully consider effects on host immune function and possible off-target effects on cell signaling[1]
06

Interacting drugs

None currently approved specifically targeting Nef; experimental small molecule inhibitors reported in the literature[1]
07

Biomarkers

Presence of Nef protein/antibodies as a marker of HIV infection; not used for routine patient selection or efficacy monitoring

Beyond the preview

Go deeper on HIV Negative Regulatory Factor (HIV Nef).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HIV Negative Regulatory Factor (HIV Nef).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call